Translating Novel siRNA & microRNA Drugs from Bench To Bedside

Discover, Develop & Selectively Deliver Highly Stable & Potent RNAi Therapeutics for Targeted & Effective Gene Silencing in Oncology, Rare, Cardiovascular Disorders & Beyond

 The 7th RNAi-Based Therapeutics Summit is the industry's premier dedicated forum for translating the next wave of siRNA and microRNA drugs from bench to bedside. As the only event uniting the entire RNAi ecosystem from discovery and complex chemistry to clinical development and CMC, this Summit provides an unparalleled platform to tackle the field's most pressing challenge: delivery beyond the liver. This is your unique opportunity to join 80+ senior leaders from pharma and biotech to gain the data-driven insights and high-value connections needed to overcome stability challenges, de-risk clinical translation, and position your pipeline at the forefront of the next therapeutic revolution. 

Good variation of talks and topics, from academic to early-stage biotech to the bigger stage biopharma players in the field of RNA therapeutics

Ruben Postel, Chief Scientific Officer, Sapreme Technologies, 6th RNAi-Based Therapeutics Summit

Sapreme Technologies

The talks are incredible, very informative and cutting edge

Kimberley McCarthy, Senior Scientist III, AbbVie, 6th RNAi-Based Therapeutics Summit

AbbVie logo

Explore the Full Event Guide

  • 25+ expert speakers from pioneering biotechs and large pharma, including Sanegene Bio, AbbVie, Judo Bio, and more, sharing exclusive data and case studies. 
  • Actionable insights to conquer extrahepatic delivery for CNS, muscle, and cardiac tissues with novel strategies like aptamers, bispecifics, and exosomes. 
  • Dedicated deep-dives on the hottest applications: from obesity and metabolic disease to neurology, oncology, and more. 
  • Critical regulatory and CMC strategies to overcome complex synthesis, scale-up, and IND-enabling hurdles for late-stage clinical success. 
7th RNAi-Based Therapeutics Summit Brochure Cover

What To Expect

80+

Attendees from Biopharma & Academia

25

World-Class Speakers

20+

C-Level
Speakers

8+

Hours of In-Person Networking

15

New Companies

2

Interactive Workshops

Attending Companies Include

AbbVie logo
Alnylam Logo
Biocogent logo
Anegene Bio logo
Curamir logo
judobio logo
RNA NanoBiotics logo
DUB Therapeutics logo
gensaic logo
Screenshot 2025-09-10 095445
Explore the Agenda

Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.

Screenshot 2025-09-10 095258
Partner With Us

Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.

Screenshot 2025-09-10 095245
Join Biopharma Experts

Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.